Delving into the Latest Updates on Beaufour Ipsen Industrie SAS with Synapse

Overview

主要目的：验证BLI800用于成人结肠镜检查（结肠镜检查是一种常规的诊断操作）前总体肠道准备的效果非劣于福静清（在中国使用的参照清肠用药）。次要目的：比较研究者对于BLI800和福静清的满意度；比较受试者对于BLI800 和福静清的满意度等。

[Translation]

Primary objective: To verify that BLI800 is non-inferior to Fujingqing (the reference bowel cleansing drug used in China) for overall bowel preparation before colonoscopy (colonoscopy is a routine diagnostic procedure) in adults. Secondary objectives: To compare investigators' satisfaction with BLI800 and Fujingqing; to compare subjects' satisfaction with BLI800 and Fujingqing, etc.

Start Date28 May 2018

Sponsor / Collaborator

Beaufour Ipsen Industrie SAS

[+2]

100 Clinical Results associated with Beaufour Ipsen Industrie SAS

Login to view more data

0 Patents (Medical) associated with Beaufour Ipsen Industrie SAS

Login to view more data

100 Deals associated with Beaufour Ipsen Industrie SAS

Login to view more data

100 Translational Medicine associated with Beaufour Ipsen Industrie SAS

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data